203 related articles for article (PubMed ID: 10810230)
1. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
[TBL] [Abstract][Full Text] [Related]
2. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
[TBL] [Abstract][Full Text] [Related]
3. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
Cohen MP; Hud E; Shea E; Shearman CW
Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
Cohen MP; Hud E; Wu VY
Kidney Int; 1994 Jun; 45(6):1673-9. PubMed ID: 7933815
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.
Cohen MP; Ziyadeh FN; Hong SW; Shearman CW; Hud E; Lautenslager GT; Iglesias-de la Cruz MC; Chen S
Kidney Int; 2002 Jun; 61(6):2025-32. PubMed ID: 12028443
[TBL] [Abstract][Full Text] [Related]
6. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
[TBL] [Abstract][Full Text] [Related]
7. Prevention of decline in renal function in the diabetic db/db mouse.
Cohen MP; Clements RS; Cohen JA; Shearman CW
Diabetologia; 1996 Mar; 39(3):270-4. PubMed ID: 8721771
[TBL] [Abstract][Full Text] [Related]
8. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP
Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208
[TBL] [Abstract][Full Text] [Related]
9. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
Cohen MP; Ziyadeh FN
J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
[TBL] [Abstract][Full Text] [Related]
10. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
11. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription.
Cohen MP; Hud E; Wu VY; Ziyadeh FN
Mol Cell Biochem; 1995 Oct; 151(1):61-7. PubMed ID: 8584015
[TBL] [Abstract][Full Text] [Related]
12. Glycated albumin promotes a generalized vasculopathy in the db/db mouse.
Cohen MP; Clements RS; Cohen JA; Shearman CW
Biochem Biophys Res Commun; 1996 Jan; 218(1):72-5. PubMed ID: 8573179
[TBL] [Abstract][Full Text] [Related]
13. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
[TBL] [Abstract][Full Text] [Related]
14. Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.
Ziyadeh FN; Cohen MP
Mol Cell Biochem; 1993 Aug; 125(1):19-25. PubMed ID: 8264568
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
16. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.
Huang Y; Border WA; Yu L; Zhang J; Lawrence DA; Noble NA
J Am Soc Nephrol; 2008 Feb; 19(2):329-38. PubMed ID: 18216319
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
Cohen MP; Lautenslager GT; Shearman CW
Metabolism; 2001 Dec; 50(12):1435-40. PubMed ID: 11735089
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
Cohen MP; Lautenslager GT; Hud E; Shea E; Wang A; Chen S; Shearman CW
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
[TBL] [Abstract][Full Text] [Related]
19. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells.
Cohen MP; Ziyadeh FN; Lautenslager GT; Cohen JA; Shearman CW
Am J Physiol; 1999 May; 276(5):F684-90. PubMed ID: 10330050
[TBL] [Abstract][Full Text] [Related]
20. Glycated albumin stimulates fibronectin and collagen IV production by glomerular endothelial cells under normoglycemic conditions.
Cohen MP; Wu VY; Cohen JA
Biochem Biophys Res Commun; 1997 Oct; 239(1):91-4. PubMed ID: 9345275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
